-$0.29 Earnings Per Share Expected for OrthoPediatrics Corp. (NASDAQ:KIDS) This Quarter

Wall Street brokerages expect that OrthoPediatrics Corp. (NASDAQ:KIDS) will report earnings per share (EPS) of ($0.29) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for OrthoPediatrics’ earnings. OrthoPediatrics reported earnings per share of ($0.31) during the same quarter last year, which suggests a positive year over year growth rate of 6.5%. The business is expected to issue its next earnings report on Wednesday, March 9th.

On average, analysts expect that OrthoPediatrics will report full-year earnings of ($0.78) per share for the current year, with EPS estimates ranging from ($0.80) to ($0.76). For the next year, analysts anticipate that the business will post earnings of ($0.56) per share, with EPS estimates ranging from ($0.80) to ($0.31). Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for OrthoPediatrics.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Wednesday, November 3rd. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.28) by $0.13. OrthoPediatrics had a negative net margin of 32.93% and a negative return on equity of 7.10%.

Several research firms have recently commented on KIDS. Piper Sandler upped their price target on shares of OrthoPediatrics from $70.00 to $80.00 and gave the company an “overweight” rating in a research report on Thursday, August 5th. JMP Securities upped their price target on shares of OrthoPediatrics from $70.00 to $77.00 and gave the company an “outperform” rating in a research report on Friday, August 6th. Finally, Zacks Investment Research lowered shares of OrthoPediatrics from a “buy” rating to a “hold” rating in a research report on Wednesday, October 6th.

KIDS traded up $1.33 during midday trading on Friday, hitting $62.15. 31,676 shares of the company traded hands, compared to its average volume of 127,232. The firm has a market cap of $1.22 billion, a price-to-earnings ratio of -39.59 and a beta of 0.73. The firm has a 50-day moving average of $65.90. OrthoPediatrics has a 52 week low of $38.01 and a 52 week high of $73.91.

In other OrthoPediatrics news, CFO Fred Hite sold 5,000 shares of the stock in a transaction that occurred on Thursday, September 2nd. The shares were sold at an average price of $71.50, for a total transaction of $357,500.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Jennifer N. Pritzker acquired 400 shares of the business’s stock in a transaction on Friday, August 27th. The shares were bought at an average cost of $64.55 per share, with a total value of $25,820.00. The disclosure for this purchase can be found here. Insiders sold a total of 8,804 shares of company stock valued at $612,712 over the last three months. 30.30% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of KIDS. Dimensional Fund Advisors LP lifted its position in OrthoPediatrics by 44.3% in the first quarter. Dimensional Fund Advisors LP now owns 115,143 shares of the company’s stock worth $5,612,000 after buying an additional 35,322 shares during the last quarter. Goldman Sachs Group Inc. lifted its position in OrthoPediatrics by 29.3% in the first quarter. Goldman Sachs Group Inc. now owns 6,318 shares of the company’s stock worth $308,000 after buying an additional 1,430 shares during the last quarter. Thrivent Financial for Lutherans lifted its position in OrthoPediatrics by 58.7% in the first quarter. Thrivent Financial for Lutherans now owns 28,394 shares of the company’s stock worth $1,384,000 after buying an additional 10,500 shares during the last quarter. Nuveen Asset Management LLC lifted its position in OrthoPediatrics by 1.2% in the first quarter. Nuveen Asset Management LLC now owns 54,569 shares of the company’s stock worth $2,660,000 after buying an additional 658 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its position in OrthoPediatrics by 9.4% in the first quarter. Ameriprise Financial Inc. now owns 78,842 shares of the company’s stock worth $3,844,000 after buying an additional 6,748 shares during the last quarter. Hedge funds and other institutional investors own 76.34% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp. is a medical device company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. Its products includes PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, RESPONSE Spine, Bandloc and Pediguard.

Read More: What is a front-end load?

Get a free copy of the Zacks research report on OrthoPediatrics (KIDS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for OrthoPediatrics (NASDAQ:KIDS)

Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.